Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

STEMIMMUNE

Financiado

Cerrado

Improving adoptive T cell transfer immunotherapy for cancer with T memory stem c...

Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells Here we seek to identify the genetic program at the basis of T memory stem cell persistence in vivo and use their properties to improve the adoptive T cell transfer for the treatment of human cancer. Adoptive cell transfer with tu... ver más

31/07/2016

HUMANITAS MIRASOLE...

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

HUMANITAS MIRASOLE SPA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

HUMANITAS MIRASOLE SPA

0.00€ | Lider

Proyectos interesantes

INCITE

Medical Technol...

Data Science

4M€ Cerrado

ROLE OF TCR AFFINITY

Medical Technol...

Data Science

100K€ Cerrado

T CELL HOMEOSTASIS

Medical Technol...

Data Science

100K€ Cerrado

OUTSOURCE

Medical Technol...

Data Science

2M€ Cerrado

PID2020-118529RB-I00

Medical Technol...

Data Science

218K€ Cerrado

MODICELL

Medical Technol...

Data Science

887K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

HUMANITAS MIRASOLE SPA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Here we seek to identify the genetic program at the basis of T memory stem cell persistence in vivo and use their properties to improve the adoptive T cell transfer for the treatment of human cancer. Adoptive cell transfer with tumour-specific T lymphocytes is currently under test in the clinic for the treatment of solid tumours such as melanoma. However, the poor persistence in vivo of adoptively-transferred cells is the major caveat to successful immunotherapy. Recent evidence suggests that CD8+ T cells derived from lymphocytes at early stages of differentiation better mediate tumour rejection due to their increased persistence, survival and proliferation in vivo. We recently identified the least differentiated human memory T cell subset, the T stem cell memory (TSCM), capable to self-renew and simultaneously generate more differentiated progeny. These TSCM are also endowed with superior immune reconstitution capacity and anti-tumor immunity (Gattinoni L, Lugli E et al. Nat Med, 2011;17:1290-97). However, the genetic program at the basis of persistence of these cells, especially under chronic stress, still needs to be defined. By studying immune reconstitution in haploidentical, T-repleted bone marrow transplantation, we will address this question and subsequently exploit this information to improve anti-tumor immunotherapy. Specifically, we will: 1. Determine whether TSCM cells are major contributors to the process of immune reconstitution as suggested by non-human primate and humanized mouse models. 2. Identify the genetic program responsible for the persistence of TSCM cells in vivo under conditions of continuous stress, i.e. the lymphopenia induced by the conditioning regimen 3. Genetically-modify tumor-specific T cells with candidate genes to improve persistence in humanized mouse tumor models. Our data will impact not only the field of adoptive immunotherapy but also of vaccination and transplantation.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores